153 related articles for article (PubMed ID: 22014083)
1. Bacillus Coagulans GBI-30 (BC30) improves indices of Clostridium difficile-Induced colitis in mice.
Fitzpatrick LR; Small JS; Greene WH; Karpa KD; Keller D
Gut Pathog; 2011 Oct; 3(1):16. PubMed ID: 22014083
[TBL] [Abstract][Full Text] [Related]
2. Bacillus coagulans GBI-30, 6086 limits the recurrence of Clostridium difficile-Induced colitis following vancomycin withdrawal in mice.
Fitzpatrick LR; Small JS; Greene WH; Karpa KD; Farmer S; Keller D
Gut Pathog; 2012 Oct; 4(1):13. PubMed ID: 23088680
[TBL] [Abstract][Full Text] [Related]
3. Bacillus coagulans GBI-30, 6086 (BC30) improves lactose digestion in rats exposed to a high-lactose meal.
Teichenné J; Catalán Ú; Mariné-Casadó R; Domenech-Coca C; Mas-Capdevila A; Alcaide-Hidalgo JM; Chomiciute G; Rodríguez-García A; Hernández A; Gutierrez V; Puiggròs F; Del Bas JM; Caimari A
Eur J Nutr; 2023 Sep; 62(6):2649-2659. PubMed ID: 37249602
[TBL] [Abstract][Full Text] [Related]
4. Effects of Bacillus coagulans GBI-30, 6086 as an adjunct starter culture on the production of yogurt.
Cao J; Yu Z; Zhang Q; Yu L; Zhao J; Zhang H; Chen W; Zhai Q
Food Res Int; 2022 Oct; 160():111398. PubMed ID: 36076366
[TBL] [Abstract][Full Text] [Related]
5. Bacillus coagulans GBI-30, 6086 Modulates Faecalibacterium prausnitzii in Older Men and Women.
Nyangale EP; Farmer S; Cash HA; Keller D; Chernoff D; Gibson GR
J Nutr; 2015 Jul; 145(7):1446-52. PubMed ID: 25948780
[TBL] [Abstract][Full Text] [Related]
6. Bacillus coagulans GBI-30, 6086 increases plant protein digestion in a dynamic, computer-controlled in vitro model of the small intestine (TIM-1).
Keller D; Van Dinter R; Cash H; Farmer S; Venema K
Benef Microbes; 2017 May; 8(3):491-496. PubMed ID: 28504581
[TBL] [Abstract][Full Text] [Related]
7. Spores of Bacillus coagulans GBI-30, 6086 show high germination, survival and enzyme activity in a dynamic, computer-controlled in vitro model of the gastrointestinal tract.
Keller D; Verbruggen S; Cash H; Farmer S; Venema K
Benef Microbes; 2019 Feb; 10(1):77-87. PubMed ID: 30694101
[TBL] [Abstract][Full Text] [Related]
8. Combined effect of
Gepner Y; Hoffman JR; Shemesh E; Stout JR; Church DD; Varanoske AN; Zelicha H; Shelef I; Chen Y; Frankel H; Ostfeld I
J Appl Physiol (1985); 2017 Jul; 123(1):11-18. PubMed ID: 28408697
[TBL] [Abstract][Full Text] [Related]
9. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis.
Buffie CG; Jarchum I; Equinda M; Lipuma L; Gobourne A; Viale A; Ubeda C; Xavier J; Pamer EG
Infect Immun; 2012 Jan; 80(1):62-73. PubMed ID: 22006564
[TBL] [Abstract][Full Text] [Related]
10. Effect of prebiotics on the fecal microbiota of elderly volunteers after dietary supplementation of Bacillus coagulans GBI-30, 6086.
Nyangale EP; Farmer S; Keller D; Chernoff D; Gibson GR
Anaerobe; 2014 Dec; 30():75-81. PubMed ID: 25219857
[TBL] [Abstract][Full Text] [Related]
11. Probiotic BC30 Improves Amino Acid Absorption from Plant Protein Concentrate in Older Women.
Walden KE; Hagele AM; Orr LS; Gross KN; Krieger JM; Jäger R; Kerksick CM
Probiotics Antimicrob Proteins; 2024 Feb; 16(1):125-137. PubMed ID: 36515888
[TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice.
Kim MN; Koh SJ; Kim JM; Im JP; Jung HC; Kim JS
World J Gastroenterol; 2014 Dec; 20(45):17084-91. PubMed ID: 25493020
[TBL] [Abstract][Full Text] [Related]
13.
Stecker RA; Moon JM; Russo TJ; Ratliff KM; Mumford PW; Jäger R; Purpura M; Kerksick CM
Nutr Metab (Lond); 2020; 17():93. PubMed ID: 33110439
[TBL] [Abstract][Full Text] [Related]
14. Critical role of MAVS in the protection against Clostridium difficile-induced colitis.
Zhang P; Mao R; Lv Z; Wang B; Su J
Microb Pathog; 2018 Dec; 125():306-312. PubMed ID: 30267893
[TBL] [Abstract][Full Text] [Related]
15. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection.
Reeves AE; Theriot CM; Bergin IL; Huffnagle GB; Schloss PD; Young VB
Gut Microbes; 2011; 2(3):145-58. PubMed ID: 21804357
[TBL] [Abstract][Full Text] [Related]
16. Synbiotic supplementation with prebiotic green banana resistant starch and probiotic Bacillus coagulans spores ameliorates gut inflammation in mouse model of inflammatory bowel diseases.
Shinde T; Perera AP; Vemuri R; Gondalia SV; Beale DJ; Karpe AV; Shastri S; Basheer W; Southam B; Eri R; Stanley R
Eur J Nutr; 2020 Dec; 59(8):3669-3689. PubMed ID: 32067099
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Bricker E; Garg R; Nelson R; Loza A; Novak T; Hansen J
Cochrane Database Syst Rev; 2005 Jan; (1):CD004610. PubMed ID: 15674956
[TBL] [Abstract][Full Text] [Related]
18. Orange Juice and Yogurt Carrying Probiotic
Almada-Érix CN; Almada CN; Cabral L; Barros de Medeiros VP; Roquetto AR; Santos-Junior VA; Fontes M; Gonçalves AESS; Dos Santos A; Lollo PC; Magnani M; Sant'Ana AS
Front Microbiol; 2021; 12():623951. PubMed ID: 34135869
[TBL] [Abstract][Full Text] [Related]
19. Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains.
Theriot CM; Koumpouras CC; Carlson PE; Bergin II; Aronoff DM; Young VB
Gut Microbes; 2011; 2(6):326-34. PubMed ID: 22198617
[TBL] [Abstract][Full Text] [Related]
20. A Spore-Forming Probiotic Supplement Improves the Intestinal Immune Response and Protects the Intestinal Health During Recurrent Clostridioides difficile Colonization in Mice.
Ramezani Kapourchali F; Glueck B; Han Y; Shapiro D; Fulmer CG; Cresci GAM
JPEN J Parenter Enteral Nutr; 2020 Nov; 44(8):1428-1438. PubMed ID: 32495964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
